We have investigated the source(s) and targeting of components to PNS nodes of Ranvier. We show adhesion molecules are freely diffusible within the axon membrane and accumulate at forming nodes from local sources, whereas ion channels and cytoskeletal components are largely immobile and require transport to the node. We further characterize targeting of NF186, an adhesion molecule that pioneers node formation. NF186 redistributes to nascent nodes from a mobile, surface pool. Its initial accumulation and clearance from the internode require extracellular interactions, whereas targeting to mature nodes, i.e., those flanked by paranodal junctions, requires intracellular interactions. After incorporation into the node, NF186 is immobile, stable, and promotes node integrity. Thus, nodes assemble from two sources: adhesion molecules, which initiate assembly, accumulate by diffusion trapping via interactions with Schwann cells, whereas ion channels and cytoskeletal components accumulate via subsequent transport. In mature nodes, components turnover slowly and are replenished via transport.
INTRODUCTION
Neurons are highly polarized cells comprised of specialized membrane domains that function in reception, integration, and propagation of electrical activity. Neurons are broadly divided into somatodendritic and axonal compartments, each of which are further organized into distinct subdomains that differ in their composition of ion channels, adhesion molecules, and cytoskeletal scaffolding proteins (Lai and Jan, 2006) . One of the most prominent subdomains is the nodal region comprised of the nodes of Ranvier, the flanking paranodal junctions, and the juxtaparanodes (Salzer et al., 2008; Susuki and Rasband, 2008 ). This organization is critical to the function of myelinated axons in saltatory conduction. Disturbances of domain organization and function are increasingly appreciated to contribute to axonal pathology in myelin disorders.
Major components of each of the nodal region domains have been identified in recent years (Salzer et al., 2008) . The nodal complex is comprised of the axonal adhesion molecules, neurofascin 186 (NF186) and NrCAM, which are both members of the immunoglobulin (Ig) superfamily of cell adhesion molecules; the ion channels, Na v 1.6, KCNQ2, and Q3; and a cytoskeletal scaffold of ankyrin G and bIV spectrin. The paranodal junctions consist of a complex of Caspr and contactin on the axon and NF155 on the apposed glial loops, whereas the juxtaparanodes contain TAG-1, Caspr 2, and the potassium channels, Kv1.1 and Kv1.2.
The mechanism of node assembly is currently best characterized in the peripheral nervous system (PNS) where NF186 plays a key role in formation of this structure (Sherman et al., 2005; Thaxton et al., 2011) . NF186 binds to gliomedin, a secreted Schwann cell protein linked to the nodal microvilli via NrCAM; gliomedin promotes (Eshed et al., 2005) , but is not essential (Feinberg et al., 2010) for, PNS node formation. NF186 initiates node assembly by recruiting ankyrin G, which in turn is critical for the stable accumulation of sodium channels, bIV spectrin (Dzhashiashvili et al., 2007) , and KCNQ (Chung et al., 2006; Pan et al., 2006) at this site. Indirect interactions mediated by bIV spectrin also are required for KCNQ accumulation (Devaux, 2010) . Initial nodal clusters, termed heminodes, form at the end of individual myelin segments; these are thought to fuse to form mature nodes (Salzer, 2003) . Mature nodes, in turn, are flanked by the paranodal junctions, which segregate ion channels at the node from those in the juxtaparanodes (Bhat et al., 2001; Boyle et al., 2001) by limiting the lateral diffusion of the nodal complex (Pedraza et al., 2001; Rasband et al., 2003; Rios et al., 2003) . Paranodal junctions also support node assembly, supplementing NF186-dependent signals in both the CNS (Sherman et al., 2005) and PNS (Feinberg et al., 2010) .
While the key components of these domains are now known, the source(s) of these components and the mechanisms that dictate their assembly remain poorly understood. In particular, it is not known whether domains assemble via the redistribution of existing proteins within the axon or on the axon surface and/or from the transport of newly synthesized proteins. In this study, we have examined the sources and targeting of proteins to PNS nodes of Ranvier. Our results support a sequential model of node assembly initiated by redistribution of mobile, surface pools of adhesion molecules that accumulate via diffusion trapping as the result of interactions with Schwann cell ligand(s); in contrast, ion channels and cytoskeletal components rely on transport from the cell soma and subsequent targeting to this site. In mature nodes, flanked by paranodal junctions, the slow replenishment of components during node maintenance depends on transport.
RESULTS

Cell Adhesion Molecules, but Not Ion Channels, Are Recruited to Domains of Transected Axons
We first investigated whether proteins assembled at domains are already present within axons or require neuronal somas as a source; the latter case would suggest that newly synthesized proteins are required. To this end, we examined domain formation following transection of Nmnat1 (Nicotinamide mononucleotide adenylyl transferase 1)-expressing neurons-similar to Figure 1D ). Consistent with the absence of cytoskeletal proteins at the heminodes of transected axons, NF186 was readily extracted from these sites by the nonionic detergent Triton X-100 (see Figure S1A available online). It was not extracted from the heminodes of uncut axons, in agreement with previous studies demonstrating that NF186 is detergent resistant when it is associated with ankyrin G (Boiko et al., 2007) .
In a minority of heminodes we did observe robust sodium channel clusters (see Figure S2A , available online); surprisingly, these were typically devoid of ankyrin G expression. We also observed occasional examples of persistent expression of sodium channels along myelinated internodal regions near the node ( Figure S2B ), suggesting that clearance of channels from the internode was partially affected in the transected axons.
This selective recruitment of CAMs, but not of channel and cytoskeletal proteins, to the heminodes of transected axons does not result from differences in the turnover or abundance of these proteins following axonal transection. Thus, western blotting analysis (Figures S1B and S1C) demonstrated comparable turnover of the nodal components NF186, NaChs, and ankyrin G at 7 days following axotomy, the approximate time the nodes were analyzed. These components were also detectably expressed in neuron-only cultures after axotomy based on immunostaining (data not shown). These findings indicate that differential recruitment to the nodes is not the result of differential availability. Rather, they suggest that CAMs and channels are directed to the node from different pools of proteins.
Accumulation of Nodal Components: Differential Dependence on Vesicular Transport
Two potential sources of axonal proteins may contribute to node assembly: (1) surface proteins that redistribute to this site, and/or (2) proteins in intracellular vesicles that are transported there. To distinguish between these possible sources further, we characterized the effect of axotomy on vesicle transport by imaging Nmnat1-labeled (Figure 2A ) or NF186-GFP labeled vesicles (data not shown) with time-lapse microscopy. Vesicle transport largely ceased 8 hr after axotomy (Figure 2A ; Movies S1 and S2) even though there were no obvious changes in the organization of microtubules or neurofilament after transection (Figure 2B) . Similar results were observed in myelinating cocultures (data not shown). As nodes did not form until 3 or 4 days after axotomy, and paranodes later still, these results strongly suggest that adhesion molecules detected at heminodes (NF186, NrCAM) and paranodes (Caspr) in the transected axons did not accumulate via transport, in contrast to ion channels and cytoskeletal proteins.
To directly examine the role of vesicular transport during node assembly, and whether newly synthesized proteins from the soma contribute, we treated neurons with brefeldin A (BFA); this treatment results in mixing of the ER and Golgi compartments, blocking anterograde, vesicular trafficking (Klausner et al., 1992) . We first confirmed that BFA blocks transport of newly synthesized proteins into the axons over extended time periods. We inducibly expressed NF186, tagged with GFP at its C terminus (Dzhashiashvili et al., 2007) , in neurons under the control of the doxycycline-inducible lentiviral vector pSLIK (Shin et al., 2006) . NF186-GFP was robustly expressed in both the cell bodies and neurites of infected neurons after doxycycline induction but only in the cell bodies of neurons treated with BFA for 3 days ( Figure 2C ). Live imaging confirmed that transport of labeled vesicles was blocked by BFA (data not shown).
As Schwann cells do not myelinate in the presence of BFA (data not shown), we established microfluidic chambers, which allowed neurons to be treated separately from Schwann cells.
In these cultures, neuronal cell bodies and their distal neurites are grown in separate compartments, connected by processes that extend through microgrooves (Taylor et al., 2005) ; Schwann cells were added to the neurite compartment and maintained under myelinating conditions ( Figure 2D ). The compartment containing the cell bodies was treated either with vehicle control (DMSO) or with BFA continuously, beginning with the onset of myelination. Cultures were then fixed, and domain markers were analyzed in the Schwann cell-neurite compartment. As shown in Figure 2E , and quantified in Figure 2F , treatment with BFA blocked accumulation of sodium channels and ankyrin G, but not that of adhesion molecules (i.e., NF186 and Caspr). Like the transected Nmnat1-protected axons, the effects of BFA were most pronounced on ankyrin G accumulation; occasional sodium channel clusters devoid of ankyrin G were observed ( Figure S2C ). These findings strongly support the notion that ion channels and their cytoskeletal scaffold require transport from the soma, whereas adhesion molecules (i.e., NF186, NrCAM) accumulate at the node from local (i.e., transport-independent) stores.
Differential Planar Mobility of Nodal Components
To investigate whether these distinct routes of accumulation correlate to differences in the planar mobility of these components, we analyzed the diffusion of each of these proteins in the axon membrane. We first nucleofected neurons with (C) BFA treatment blocks axonal transport of newly synthesized proteins. DRG neurons were infected with the doxycycline-inducible lentiviral construct pSLIK-NF186-EGFP. Upon induction of NF186-EGFP, neurons were treated with either 1.0 mg/ml BFA or DMSO (vehicle control) and after 3 days, were fixed and stained for GFP (green) and neurofilament (red). NF186-EGFP was expressed in both neuronal somas and neurites in control cultures, but only in the somas of BFAtreated cultures. Scale bar, 25 mm.
(D) Myelination in microfluidic chamber cultures. Neuronal somas and distal neurites (stained for neurofilament in green) were grown in different microfluidic culture compartments, separated by microgrooves. Schwann cells were added to the neurite compartment and myelinated appropriately after 8 days in myelinating media. The inset demonstrates one field at higher magnification in order to highlight MBP-positive segments; for clarity only the red channel is shown. Scale bar, 100 mm.
(E) BFA treatment blocked nodal accumulation of sodium channels and ankyrin G, but not NF186 and Caspr. BFA was added to the compartment containing neuronal somas prior to initiating myelination in the neurite compartment. Representative images showing expression of nodal and paranodal components in control (DMSO) and BFA-treated cultures (7 days of myelination, the last 5 with DMSO or BFA); MBP segments (blue) are also shown. Scale bar, 3 mm. GFP-tagged NF186 (Dzhashiashvili et al., 2007) , NrCAM, Na V 1.2, KCNQ3, and ankyrin G constructs. We analyzed Na V 1.2, which is expressed transiently at forming PNS nodes (Boiko et al., 2001; Rios et al., 2003) and is more readily expressed after transfection of neurons than Na V 1.6 (Lee and Goldin, 2009 ). Each of these constructs was diffusely expressed along unmyelinated axons and localized appropriately to heminodes ( Figure 3A ) and nodes (insets, Figure 3A ) of Ranvier with myelination. (E) NF186 incorporated into the node is effectively immobile. One-half of a node in which NF186-EGFP is concentrated (which appears as two linear signals due edge effects) was photobleached (demarcated by the red box). No recovery was detected even 2.5 min after photobleaching. Scale bar, 2 mm.
We next measured the mobility of these nodal components in individual, unensheathed neurites by FRAP (fluorescence recovery after photobleaching) (Snapp et al., 2003) . Representative results from photobleaching experiments are shown in Figure 3B; intensity measurements ( Figure 3C ) and a summary of the calculated mobilities ( Figure 3D ) are also shown. In general, NF186 and NrCAM were uniformly mobile with diffusion coefficients for NF186 of 0.338 ± 0.022 mm 2 /s (mean ± SEM, n = 12) and for NrCAM of 0.198 ± 0.016 mm 2 /s (n = 6); in both cases, the fluorescence recovery was nearly complete, indicating that the population is fully mobile. In contrast, the mobility of ion channels Na V 1.2 and KCNQ3 were significantly reduced and more variable. For Na v 1.2, three broad patterns were detected: (1) fluorescence recovery was extensive, but mobility was slow (p1, Figure 3C ), i.e., D = 0.115 ± 0.046 mm 2 /s (n = 9 out of 20 samples); (2) mobility was negligible (p2, Figure 3C ), i.e., D = 0.045 ± 0.001 mm 2 /s (n = 6 out of 20 samples); or (3) Na v 1.2 was effectively immobile (p3, Figure 3C ), and there was almost no recovery of fluorescence (n = 5 out of 20 samples). KCNQ3 also exhibited populations that were either slowly mobile (p1, Figure 3C ; D = 0.055 ± 0.011 mm These results indicate a striking difference in the mobility of nodal components prior to myelination: adhesion molecules are highly mobile within the plane of the membrane, whereas a significant proportion of ion channels and the entire population of ankyrin G are effectively immobile. The mobility of these components correlates well with their ability to accumulate at nodes in transected axons and following BFA treatment, i.e., adhesion molecules reliably accumulate, sodium channels accumulate in a small percentage of nodes, and ankyrin G does not accumulate.
Finally, we measured the mobility of NF186-EGFP after it incorporated into the node ( Figure 3E ). In contrast to its extensive mobility on isolated axons, NF186 at the node was effectively immobile with essentially no recovery after photobleaching.
NF186 Redistributes from a Surface Pool
The finding that adhesion molecules are highly diffusible within the membrane and accumulate at the node from local stores suggested that they might concentrate by redistributing from an existing surface pool. To address this possibility, we selectively labeled NF186 at the axonal surface. We placed the AviTag epitope (Beckett et al., 1999; Howarth et al., 2005) within the NF186 ectodomain immediately after the FNIII repeats (Figure 4A) ; GFP was fused to the C terminus. The AviTag epitope is biotinylatable by BirA, a membrane-impermeable bacterial, biotin ligase, and therefore, only NF186 expressed at the axon surface will be biotinylated. The construct was subcloned into a lentiviral expression vector and expressed in DRG neurons. AviTag-NF186 was readily biotinylated in a BirA ligase-dependent fashion based on western blot analysis (data not shown) and live labeling of cultures with streptavidin-conjugated Alexa Fluor 568 ( Figure 4B ), indicating that it is expressed at the axon surface. In contrast, the wild-type (WT) NF186 construct lacking the AviTag was not biotinylated ( Figure 4B ). We next expressed AviTag-NF186 in DRG neurons, selectively biotinylated the surface pool with BirA, and then cocultured with Schwann cells under myelinating conditions for an additional 5 days. Cultures were live labeled with streptavidin conjugated to Alexa 568 to visualize the biotinylated construct. We found that NF186, which is diffusely expressed on the surface of premyelinating axons ( Figure 4C ), is robustly and selectively expressed at nodes of myelinated fibers ( Figure 4C ). The great majority (>90%) of nodes in nerve fibers that expressed AviTag-NF186 were strongly labeled with streptavidin-Alexa 568. Labeling at the node was typically significantly higher than that observed along background, unmyelinated fibers in the same cultures, suggesting that the construct becomes concentrated at the node via redistribution.
NF186 Is Highly Stable after Incorporation into Nodes
To address the mechanism(s) by which NF186 is targeted to mature nodes, we first characterized its stability at nodes of Ranvier by shRNA knockdown of its expression in established myelinated cocultures. As previously reported (Dzhashiashvili et al., 2007) , this shRNA construct reduced expression of NF186 in newly plated neurons by >95% ( Figures S3A and 3B) ; a comparable knockdown was obtained when the same shRNA construct was introduced into mature neuron cultures (Figures S3C and S3D) . We next compared turnover of NF186 in neuron-only cultures versus that at nodes of myelinated cocultures. In established, neuron-only cultures, NF186 turns over rapidly with a half-life of 5 days based on decay of the surface pool, identified by biotinylation and immunoprecipitation ( Figures S4A and S4B) ; similar results were observed after shRNA knockdown of the total pool (data not shown). Nodes that form when shRNA-treated neurons are myelinated are effectively devoid of NF186 ( Figure 5A , left panel) and, as we have previously shown (Dzhashiashvili et al., 2007) , all other nodal components. In contrast, NF186 is extremely stable after incorporation into nodes ( Figure 5A , right panel). Quantification of the decline in the intensity of NF186 after shRNA treatment of mature myelinating cocultures, assessed by confocal microscopy (Figure 5B) , demonstrated a half-life of 7 weeks at heminodes and 3 months at nodes.
In complementary studies, we observed a significant difference in the extractability of NF186 by the nonionic detergent Triton X-100. In neuron-only cultures, NF186 was substantially removed along the neurites ( Figure S4C ), whereas at nodes (and heminodes) in the cocultures it was not ( Figure S4D ). The detergent extraction data suggest that NF186 is not associated with the cytoskeleton until it is recruited to the node, likely accounting for its enhanced stability at this site.
We also examined sodium channel levels after knockdown of NF186 in mature cocultures. Ten weeks after shRNA treatment, average sodium channel intensity was reduced to 32% at heminodes and 65% at nodes compared to control cultures ( Figure 5C ), which correlates well with the reduction of NF186 (35% at heminodes and 52% at nodes; Figure 5B ). Together, these data indicate that NF186 exhibits slow turnover at nodes and heminodes, which correlates to its recruitment into a detergent-insoluble complex. Continued expression of NF186 is required to maintain full expression of sodium channels at the node.
NF186 Is Targeted Directly to Mature Nodes via Cytoplasmic Domain Interactions
The turnover of NF186 at mature nodes, while modest, raises the question of how it is replenished at these sites. As mature nodes are flanked by paranodal junctions, which function as barriers to the lateral diffusion of axolemmal proteins, redistribution of NF186 from surface pools seemed unlikely. Rather, we considered that replacement of nodal components might rely on proteins transported in carrier vesicles that are inserted at this site, allowing them to bypass the junctions. We also reasoned that targeting of NF186 to the node from transport vesicles might be different than its targeting from surface pools. NF186 is targeted to nascent heminodes and nodes via its extracellular sequences (Dzhashiashvili et al., 2007) . However, because the ectodomain of NF186 carried by transport vesicles is intraluminal and, therefore, inaccessible as a targeting signal, the cytoplasmic, i.e. the extraluminal segment of transported NF186 might instead target it to mature nodes. To investigate whether NF186 is indeed targeted via distinct signals during node formation and maintenance, i.e., via its ectodomain and cytoplasmic sequences, respectively, we analyzed targeting of a series of NF186 constructs (see Figure 6A ). These included WT NF186, NF186 in which the ankyrin G binding domain was deleted (NFDABD), and chimeric constructs in which the ectodomain or cytoplasmic domains of NF186 were replaced with the cognate domains of ICAM-1, i.e., ICAM1ecto-NF186cyto (ICAM/NF) or NF186ecto-ICAM1cyto (NF/ICAM). ICAM-1 is a lymphocyte IgCAM of similar molecular weight to NF186; we previously demonstrated that it is diffusely distributed along the length of myelinated axons when it is ectopically expressed in neurons, indicating that it lacks specific targeting or clearance signals during myelination (Dzhashiashvili et al., 2007) . These constructs were subcloned into the pSLIK vector. DRG neurons were then infected with the lentiviral constructs and cocultured with Schwann cells under myelinating conditions. Expression of each construct was strictly dependent on doxycycline ( Figure 6B) .
We induced expression (1) just prior to the onset of myelination to examine targeting to forming nodes, and (2) in established myelinating cocultures to examine targeting to existing heminodes and mature nodes. Targeting of these constructs during node formation and maintenance was distinct. Constructs that contain the NF186 ectodomain (i.e., NF186, NF186DABD, and NF/ICAM) were targeted appropriately to forming nodes (Figure 6C ) and heminodes ( Figure S5A ) and cleared from the internode; quantification is shown in Figure 6E . In contrast, ICAM/NF, which contains only the cytoplasmic domain of NF186, was not targeted to nodes nor cleared from the myelinated internode ( Figure 6C ). These results are consistent with our previous report that the ectodomain of NF186 is essential for initial targeting to nodes and clearance from the internode (Dzhashiashvili et al., 2007) .
We next induced expression of these constructs in established cocultures that had myelinated for 6-8 weeks beforehand. Myelination is largely complete in such cocultures as evidenced by the stable numbers of nodes and heminodes even after an additional 3 weeks of coculture ( Figure S6 ). In contrast to forming nodes, only WT NF186 and ICAM/NF were targeted appropriately to mature nodes, i.e., those flanked on both sides by paranodes, whereas NF/ICAM and NF186DABD were not targeted ( Figures  6D and 6F) . Also in contrast to young cocultures, ICAM/NF was expressed at much lower levels along the internodes of most myelinated fibers. Extraction of such cultures with Triton X-100 prior to fixation eliminated residual ICAM/NF from the internode, but not the nodes, where it remained colocalized with ankyrin G (Figure S5C ). These latter results support the notion that binding to ankyrin G promotes stable expression of NF186 at mature nodes. Interestingly, ICAM/NF is not targeted to heminodes in these cultures ( Figures 6F and S5B ) despite the enrichment of ankyrin G at these sites. These results indicate that the cytoplasmic domain of NF186 is sufficient to mediate targeting to mature nodes, whereas the ectodomain is also required for targeting to heminodes.
Taken together, these results indicate that NF186 is targeted to nascent nodes and mature nodes by distinct mechanisms: ectodomain sequences are necessary and sufficient for initial accumulation at heminodes and newly formed nodes, whereas intracellular sequences are necessary and sufficient for targeting and stable accumulation at mature nodes. They also suggest that the paranodes modify the mechanisms by which NF186 accumulates at nodes.
Targeting of NF186 in Transgenic Mice: Nascent versus Mature Nodes
To extend these findings, we generated transgenic mice expressing WT NF186, NF/ICAM, and ICAM/NF under the control of the neuron-specific Thy-1.2 promoter (Aigner et al., 1995; Feng et al., 2000) . Each construct was tagged with EGFP at the C terminus. We generated several founders for each construct and analyzed expression by staining for GFP. The overall pattern of expression was similar for different founders that expressed the Cultures were infected with lentiviral constructs encoding shRNA to NF186 or control (scrambled, Scr) sequences and stained for NF186 (red) and Caspr (blue); nerve fibers infected with the lentiviral constructs are GFP+ (green). Left panels show that NF186 was not detected at nodes when neurons were treated with shRNA 3 weeks prior to the onset of myelination. Right panels illustrate that NF186 continued to be robustly expressed at nodes (arrowheads) when neurons were treated with shRNA 6 weeks after myelination had commenced and continuing for 1 month more; expression at heminodes (arrow) was slightly reduced. Scale bar, 10 mm.
(B) The relative intensities of NF186 at heminodes and nodes of neurons treated with shRNA to NF186 versus scrambled (control) sequences were determined following shRNA treatment; knockdown of NF186 by the shRNA construct was initiated 6 weeks after myelination and continued for the times shown. (B) Inducible expression of NF constructs in DRG neurons is doxycycline (1 mg/ml) dependent; peripherin is used as a loading control. (C) Representative images of the targeting of different constructs to nascent node (indicated by white arrows). Doxycycline was added to cultures prior to switching to myelinating media; these were maintained under myelinating conditions for an additional 7-10 days. Scale bar, 6 mm.
(D) Representative images of the targeting of different constructs to mature nodes (indicated by white arrows). Doxycycline was added to cocultures that had already myelinated for 6 weeks; these were then maintained for an additional 1-2 weeks. Scale bar, 6 mm.
(E) Quantification of the targeting of constructs to nascent nodes is presented as a percentage of the total nodes on GFP-positive fibers.
(F) Quantification of the targeting of constructs to mature nodes is presented as the ratio of positively nucleated nodes versus total nodes in the scanned fields.
same construct. Representative images for one founder line for each construct are shown at different postnatal ages in Figure 7A . NF186 and NF/ICAM were concentrated at nodes (arrowheads, Figures 7A and 7B ) and heminodes (arrows, Figure 7B ) by postnatal day 3 (P3), the earliest time point analyzed. While WT NF186 persisted at nodes at all time points examined, NF/ICAM was greatly reduced at nodes at P14 and largely absent in the adult, indicating that stable nodal expression of NF186 requires cytoplasmic interactions, presumably with ankyrin G. No significant internodal staining was observed for either construct at any of the time points examined; unmyelinated and premyelinated axons expressed both constructs along their length at high levels (data not shown). In contrast, ICAM/NF was only modestly enriched at nodes at P3 (Figures 7A and 7B) but progressively concentrated at nodes over time into adulthood. It was expressed at high levels along the internode at P3 and P14, consistent with a requirement for the NF186 ectodomain in internodal clearance (Dzhashiashvili et al., 2007) ; its expression along the internode of adult nerves was limited. Notably, while ICAM/NF was enriched at many nodes, it was not enriched at heminodes at P3 ( Figure 7B ), a time when heminodes are still abundant; this lack of heminode expression contrasts to that of WT NF186 and NF/ICAM. The differences in the localizations of these constructs at P3 and in the adult are quantified in Figure 7C .
To assess the association of these NF constructs with the cytoskeleton, we extracted sciatic nerves with Triton X-100, then fixed and stained for GFP ( Figure 7D ) similar to our analysis of the cocultures. As expected, WT NF186 was detergent resistant, whereas NF/ICAM was extracted from nodes and heminodes at P3. In contrast, ICAM/NF was extracted from nodes and the axon at P3, but not from nodes at P14 ( Figure 7D ). These results are quantified in Figure 7E and suggest that while ICAM/NF accumulates at the node by P3, it is not yet stably associated with the cytoskeleton.
DISCUSSION
In this study, we have examined the sources of axonal proteins that contribute to node formation and maintenance. We demonstrate that the adhesion molecules NF186 and NrCAM are recruited to nascent nodes from diffusible, preexisting surface pools, whereas ion channels and cytoskeletal components, which are mostly immobile, rely on transport. We have characterized the targeting of NF186 further and show that it redistributes to nascent nodes via ectodomain interactions, whereas it is replenished at mature nodes by direct targeting that relies on intracellular interactions. These findings, summarized schematically in Figure 8 , and their implications for the mechanisms of node assembly and maintenance are discussed below.
Distinct Sources of Proteins Contribute to Node
Assembly: Mechanistic Implications A key finding is that adhesion molecules that nucleate the domains of myelinated axons are likely to redistribute from existing pools on the axon surface. Thus, NrCAM and NF186 accumulated at heminodes, and Caspr at paranodes, during myelination of transected Nmnat1-protected axons or in BFA-treated microfluidic cocultures indicating that they are derived from local sources and do not require transport from the soma. The accumulation of a surface biotinylated AviTag-NF186 construct at newly formed nodes and heminodes provides direct evidence that it redistributes from a surface pool ( Figure 4C ). While a formal possibility, transcytosis of surface proteins (Wisco et al., 2003) , i.e., internalization of extranodal surface pools for transport and exocytosis at the node, is unlikely to account for redistribution of this surface pool given the rapid arrest of transport following axon transection.
Our results further suggest that these adhesion molecules accumulate at nascent nodes via diffusion trapping. This mechanism was originally proposed to account for the accumulation of acetylcholine receptors at the neuromuscular junction (Edwards and Frisch, 1976) . Recent results provide direct evidence for this mechanism (Geng et al., 2009) and support a general role at other synapses (Dityatev et al., 2010; Opazo and Choquet, 2011) . In the case of the node, this mechanism is consistent with lateral mobility of NF186 and NrCAM prior to myelination (Figure 3) . The mobility of NF186 likely is due to phosphorylation of its ankyrin binding site, which is spatially restricted to the axon, but not the AIS, and blocks its association with ankyrin G (Boiko et al., 2007 ; see also Figure S4C ). The diffusibility of these adhesion molecules should facilitate their ''trapping'' by interactions with cognate Schwann cell ligands. In agreement, the accumulation of axonal adhesion molecules at nodes and paranodes is mediated by trans interactions of these adhesion molecules with Schwann cells (Eshed et al., 2005; Lustig et al., 2001; Rios et al., 2000) . We previously demonstrated (Dzhashiashvili et al., 2007) , and confirm here ( Figures 6C and 7A) , that NF186 is targeted to heminodes and forming nodes via extracellular interactions that do not require its cytoplasmic segment. The ectodomains of NF186 and NrCAM bind to gliomedin, a key Schwann cell receptor that accumulates at the nodal microvilli just prior to NF186 (Feinberg et al., 2010) . Gliomedin is both necessary for the accumulation of NF186 at heminodes and sufficient to concentrate NF186, NrCAM, and other components of the node on axons (Eshed et al., 2005; Feinberg et al., 2010) . These results strongly suggest that gliomedin initiates node formation by driving the initial accumulation of NF186. In agreement with the notion of diffusion trapping, NF186 is immobile after incorporation into the node ( Figure 3E ). As NF186 is also immobile at the AIS (Boiko et al., 2007) , other mechanisms may contribute to restricting its diffusion at the node, including interactions with ankyrin G and the packing density of transmembrane proteins (Rasband, 2010) . The paranodal junctions, which function as lateral diffusion barriers at mature nodes (Rasband et al., 2003; Rios et al., 2003) , provide an additional constraint on mobility.
In contrast, ion channels (Na V , KCNQ) and their associated cytoskeletal proteins (ankyrin G and bIV spectrin) accumulate at forming nodes primarily via transport based on the transection ( Figures 1C and 1D ) and BFA experiments ( Figure 2E) . A transport-dependent source was previously suggested for sodium channels, as their clustering by oligodendrocyte-conditioned medium was blocked by BFA treatment (Kaplan et al., 2001 ). The dependence on transport is also consistent with the limited planar mobility of Na V 1.2, KCNQ3, and ankyrin G (Figure 3) , which likely precludes their ability to redistribute. Interestingly, Na V 1.2 and KCNQ3 exhibit significant variability in their mobility, ranging from slowly mobile to essentially immobile populations, on different axon segments. It is not yet clear whether this variation corresponds to differences in the composition of ion channel complexes (Rasband, 2010; Zhang et al., 2011 ) that may affect their association with the cytoskeleton, and mobility, either regionally along the length of an axon or between different axons. As axon transection (Figure 2A ) and BFA treatment ( Figure 2C ; Campenot et al., 2003) arrest axonal transport, our data do not establish whether the vesicles that transport ion channels and cytoskeletal components to the node are already present within the axon or require export from the soma, representing newly synthesized proteins.
Together, these findings support a model of sequential node assembly that relies on distinct sources. NF186, which pioneers PNS node formation (Dzhashiashvili et al., 2007; Lambert et al., 1997; Sherman et al., 2005; Thaxton et al., 2011) , together with NrCAM, diffuses to the node where it is initially ''trapped'' via gliomedin interactions. NF186 then recruits ankyrin G, which accumulates with a slight delay (Lambert et al., 1997) , and thereby sodium channels and bIV spectrin (Dzhashiashvili et al., 2007) , which are delivered by transport. Triton X-100 extraction studies ( Figure S4C ) support the notion that adhesion molecules are not part of a preformed complex with ion channels and cytoskeletal elements that redistributes en masse to the node. Whether sodium channels, ankyrin G, and bIV spectrin are transported as a complex themselves, akin to that of the presynaptic complex (Jin and Garner, 2008) , or are transported separately and assemble locally at the node, is not yet known.
In potential support that ankyrin G and ion channels may be targeted separately to the node, sodium channels accumulated in the absence of ankyrin G at a small number (20%) of the newly formed heminodes and nodes in the transected axon and BFA experiments ( Figure S2A ). These occasional channel accumulations are consistent with an earlier report that sodium channels can accumulate at heminodes during remyelination of Wld slow -transected axons (Tzoumaka et al., 1995) . In view of the effects of BFA and transection on transport, these sodium channels would appear to accumulate by a transport-independent mechanism-potentially via redistribution of the subset of (B) Node assembly. NF186 on the axon surface redistributes via diffusion to the node where it is ''trapped'' by interactions with the gliomedin/NrCAM complex on Schwann cell microvilli (MV). Sodium channels, which are shown complexed in some cases to ankyrin G in transport vesicles, are delivered for exocytosis; whether these components all traffic by fast transport and are delivered together or separately is not yet known. Nodal components along the internode are also downregulated (transparent components); early paranodal junctions (PNJ) are also illustrated. (C) In mature nodes, all node components are shown being delivered by transport of carrier vesicles, replenishing components that slowly turn over. At the node, NF186 is linked to sodium channels via ankyrin G. The flanking paranodal junctions provide a lateral diffusion barrier and may direct targeting to the node. While NF186 is illustrated as being in separate transport vesicles from those carrying sodium channels and ankyrin G, the precise composition of transport vesicles remains to be established, including whether ankyrin is transported separately by slow transport. NrCAM and other components of the node are not shown to simplify the figure. channels that are diffusible along the axon (Figures 3C and 3D) . Unexpectedly, these results also indicate that a subset of sodium channels are neither bound to nor dependent on ankyrin G for targeting to the node. These findings contrast with our previous report that assembly of the node, in particular the accumulation of sodium channels, is strictly dependent on ankyrin G expression (Dzhashiashvili et al., 2007) . As the current experiments were short-term studies, up to 1 week, whereas our previous studies relied on knockdown of ankyrin G in cocultures for 1 month or more, ankyrin G may be required primarily for stable expression rather than for targeting of this subset of channels. These results suggest that other regions of the sodium channel (Fache et al., 2004; Lee and Goldin, 2009 ) and/or interactions mediated by their b subunits (McEwen and Isom, 2004; Ratcliffe et al., 2001 ) may contribute to nodal localization.
Stability of NF186 at Mature Nodes
We have also found that NF186 is remarkably stable at mature nodes, with a half-life of 3 months in vitro based on shRNA knockdown ( Figure 5B ). This is consistent with a recent study demonstrating that NF186, genetically inactivated in adult mice, exhibits slow turnover, i.e., weeks to months, at CNS nodes of Ranvier (Zonta et al., 2011) . These results, and that of a conditional knockout of NF155 (Pillai et al., 2009) , the glial component of the paranodes, indicate that mature nodes and paranodes are relatively stable structures. The stability of these various myelinated domains likely facilitates their ability to function cooperatively to ensure the fidelity of saltatory conduction along myelinated axons.
The slow turnover of NF186 at nodes contrasts with its rapid turnover in neuron-only cultures, with a measured half-life of less than 1 week based on surface biotinylation studies ( Figures  S4A and S4B ) and shRNA analysis (data not shown). The turnover of NF186 on axons is further accelerated when neurons are cocultured with Schwann cells (Dzhashiashvili et al., 2007) and in the absence of ankyrin G interactions (Dzhashiashvili et al., 2007) ; it is also much more rapid at nodes in the absence of ankyrin G interactions based on the turnover of NF/ICAM constructs in transgenic mice ( Figure 7A ). Interactions with ankyrin G may delay turnover of NF186 by masking internalization signals (Anderson et al., 2005) . Interestingly, NF186 turns over much more rapidly at the AIS, with correspondingly larger effects on the integrity of the sodium channel complex, than at nodes (Zonta et al., 2011) . The presence of the flanking paranodes may contribute to the relative stability of NF186 expression at the node, as suggested by its slower turnover at nodes versus heminodes ( Figures 5B and 5C ). Finally, loss of NF186 is also associated with a corresponding loss of sodium channels (Figure 5C ; see also Zonta et al., 2011) , indicating that NF186 has a key role in both node assembly and maintenance. This latter role may contribute to the loss of nodal integrity and neurological disability in specific demyelinating disorders (Lonigro and Devaux, 2009 ).
Differential Trafficking Mechanisms to Nascent versus Mature Nodes
We also show that NF186 is targeted differently to nascent and mature nodes. Whereas NF186 is targeted to newly formed heminodes and nodes by its extracellular segment, it is targeted to mature nodes by its cytoplasmic domain ( Figures 6C, 6D , and 7A). Thus, replenishment of adhesion molecules and the initial and presumably subsequent targeting of ion channels rely on intracellular sources of proteins that are transported and targeted to nodes via cytoplasmic interactions. A striking and related finding is that ICAM/NF is targeted to mature nodes, i.e., those flanked by paranodes, but not to heminodes ( Figures  6F, 7A , and S5B). These findings indicate that this construct does not accumulate at nodes by first concentrating at heminodes. They also indicate that it does not redistribute from the internode as its expression was induced in established cocultures, in which the majority of nodes were already flanked by paranodes, which provide a barrier to diffusion. Furthermore, staining along the internode after induction was modest compared to the node ( Figure 6D ) even though this construct is poorly cleared from the internode.
Together, these findings suggest that ICAM/NF, and by analogy WT NF186, is directly targeted to and/or selectively inserted at mature nodes by a mechanism dependent on cytoplasmic interactions. The specific cytoplasmic interactions that direct the ICAM/NF construct to the node remain to be established. Interactions with ankyrin G are necessary for stable expression, consistent with the failure of NFDABD to accumulate at mature nodes ( Figure 6D ), but are not sufficient to specify targeting to mature nodes as ankyrin G is also enriched at heminodes. In agreement, ICAM/NF at nodes of transgenic mice was extracted by detergent at P3, but not P14 ( Figures 7D and 7E ), suggesting that it is targeted first and associates with ankyrin G after a delay. Potentially, interactions with specific adaptors and motor proteins may confer specificity to ICAM/NF targeting. A complementary possibility is that insertion of nodal proteins along the myelinated internode may be suppressed (Salzer, 1997) . Both mechanisms, i.e., specific targeting and suppression of inappropriate protein insertion, are thought to cooperate to target synaptic proteins, and promote synaptogenesis, to specific sites along the axon (Goldstein et al., 2008; Jin and Garner, 2008) .
The selective targeting of ICAM/NF to mature nodes also suggests that the paranodal junctions play a role in regulating trafficking of nodal components, in addition to their established function as membrane diffusion barriers (Rosenbluth, 2009) . By promoting targeting to the node and restricting lateral diffusion, the paranodes may enhance accumulation of ICAM/NF at mature nodes (versus heminodes). A role in regulating targeting to the node is also consistent with the recent demonstrations that the paranodes can promote sodium channel accumulation even in the absence of nodal adhesion molecules (Feinberg et al., 2010; Sherman et al., 2005) . It may further explain the requirement for the paranodes in promoting the transition from Na V 1.2 to Na V 1.6 at CNS nodes during development (Rasband et al., 2003; Rios et al., 2003) .
Complementary Mechanisms Promote Node Assembly and Maintenance
In summary, nodes assemble and are maintained by distinct protein sources and complementary targeting mechanisms. Cell adhesion molecules accumulate at the node by diffusion trapping from preexisting surface pools; once concentrated, they recruit ankyrin G, bIV spectrin, and ion channels (Dzhashiashvili et al., 2007) , which are transported to this site. Redistribution of existing sodium channels, independent of ankyrin G, may be an additional mechanism for sodium channel accumulation at some nodes. The paranodal junctions, which form after adhesion molecules have already accumulated at PNS nodes (Salzer, 2003) , limit further diffusion of node components into or out of the node, promoting instead direct trafficking. This, in turn, provides a mechanism to replenish components that are slowly turning over and/or are replaced during node maturation, e.g., channel isoforms. In addition to these mechanisms, selective clearance from the internode further reinforces the localization of node components; clearance of NF186 depends on interactions mediated by its ectodomain (Dzhashiashvili et al., 2007;  Figure 7A ).
Important details of this model remain to be elucidated. Direct evidence for the trafficking of vesicles to and fusion at the node is currently lacking. Axonal transport is known to be delayed in the nodal region (Armstrong et al., 1987) , manifest in part by the accumulation of vesicles and tubulovesicular components at this site (Zimmermann, 1996) . In addition, proteins that promote membrane fusion are enriched in the nodal region (SNAP25, NSF) and have been implicated in node assembly (Woods et al., 2006; Zimmermann, 1996) . Recent data provide evidence that activity-dependent regulation of calcium channels, enriched at the node, may regulate both local transport and node assembly (Alix et al., 2008; Zhang et al., 2010) . Further studies to examine which components traffic together, how they are transported to and inserted at nodes, and how they are cleared from extranodal sites will provide important additional insights into the assembly of this crucial axonal domain. They should also further elucidate mechanisms that underlie the assembly and maintenance of other neuronal domains and the reorganization of axonal domains during demyelination and remyelination.
EXPERIMENTAL PROCEDURES Myelinating Cocultures and Microfluidic Chamber Experiments
Cocultures of rat Schwann cells and DRG neurons were established as described previously (Einheber et al., 1993) with minor modifications (see Supplemental Experimental Procedures for detailed protocols). For experiments analyzing nascent node formation, cultures were maintained in myelinating condition for less than 2 weeks. For experiments analyzing mature nodes, cultures were maintained in myelinating media for 6-8 weeks before experiments were carried out.
Microfluidic chambers (Xona Microfluidics, LLC) were assembled onto coverslips first coated with poly-L-lysine (0.5 mg/ml in 1 3 PBS) then with laminin (10 mg/ml in water). Dissociated DRG neurons were plated in the soma chamber. NGF concentrations were higher in the distal chamber (50 ng/ml) than in the soma chamber (15-20 ng/ml) to promote the growth of neurites into the distal chamber. To assess the effect of blocking vesicular transport on domain assembly, BFA (1.0-2.5 mg/ml) was added to the soma chamber only. Simultaneously, Schwann cells were added to, and cultured with neurites in the distal compartment under myelinating conditions. DMSO was used as a vehicle control. BFA was added to the soma chamber when the cocultures in the distal chamber had been in myelinating media for 2-3 days, i.e., just prior to the appearance of the first myelin segments. BFA treatment was continued for an additional 5 days, and cultures were then fixed for analysis. In all BFA experiments, we expressed Nmnat1 in neurons by lentiviral infection to enhance survival during the several days of required treatment.
FRAP FRAP experiments were carried out with a Zeiss LSM 510 microscopy with the 633 oil immersion objective; FRAP analysis was performed as previously reported (Snapp et al., 2003) . EGFP-tagged constructs were nucleofected into DRG neurons, and cultures were analyzed by FRAP after an additional 2-3 weeks. Cultures were pretreated with 33 nM Nocodazole (Sigma-Aldrich), a microtubule-disrupting agent that blocks axonal transport, for 4 hr prior to photobleaching to prevent vesicular transport that might confound analysis. Cultures were maintained in phenol red-free NB media buffered with 10 mM HEPES at 37 C during the experiment. The diffusion coefficient was determined using an inhomogeneous diffusion simulation program developed and provided by Dr. E. Siggia (Siggia et al., 2000) .
Live Imaging of Vesicle Trafficking DRG explants were plated onto single-well MatTek cell culture dishes, and then infected with a lentivirus encoding mCherry-tagged cytNmnat1; in some experiments, neurons were coinfected with a lentivirus driving expressing NF186-EGFP expression. Cultures were cycled with antimitotics to eliminate non-neuronal cells and maintained in phenol red-free NB media. Cultures were imaged either with explants intact or at 0, 8, and 15 hr post-excision and removal of explants. During imaging the stage was maintained at 37 C; media were buffered with 10 mM HEPES (pH 7.4). Imaging was performed using an Olympus IX71 inverted microscope driven by IPLab software (BD Biosciences) with a 603 PlanApoN objective (NA 1.42). Images were collected at 5 s intervals for 12 min using a Hamamatsu EM-CCD camera.
Biotinylation and Detection of AviTag NF186 Construct
Live cultures, expressing AviTag-NF186 in neurons, were washed with biotinylation buffer (DMEM supplemented with 5 mM MgCl 2 ) once, and incubated in biotinylation solution containing 0.3 mM BirA ligase, 10 mM d-biotin, and 1 mM ATP (Avidity) in biotinylation buffer for 15 min at 37 C. Cultures were then washed with HBSS containing Ca 2+ and Mg 2+ and incubated with 10 mg/ml streptavidin-Alexa Fluor 568 (Invitrogen) in DMEM/10 mM HEPES/ 1%BSA for 10 min at room temperature. After subsequent washes, cultures were fixed in 4% PFA and processed for immunofluorescence.
Antibodies, Immunohistochemistry, Immunoblotting, and Imaging Methods Most of these reagents and procedures have been described previously (Dzhashiashvili et al., 2007) ; full details are provided in the Supplemental Experimental Procedures.
Generation and Expression of Lentiviral cDNA Constructs in Cocultures
A detailed description of these constructs and lentiviral infection of myelinating cultures is in the Supplemental Experimental Procedures.
Animal Husbandry and Generation of Transgenic Lines
The generation of transgenic mice expressing NF186-EGFP, NF/ICAM-EGFP, and ICAM1/NF-EGFP under the control of the Thy-1.2 promoter is described in the Supplemental Experimental Procedures. All experiments with these and other rodent lines were performed in compliance with the relevant policies and institutional guidelines and were approved by the New York University School of Medicine Institutional Animal Care and Use Committee.
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